Headlines
•Cerebras Systems prices IPO targeting $4.8 billion raise — Polymarket bets on $50 billion+ first-day valuation
•Transcript: MediPharm Labs Q1 2026 Earnings Conference Call
•Jim Cramer Calls NVIDIA’s Investment in Nebius a “Big Deal”
•Micron stock in focus as Wall Street weighs AI demand outlook
•Lilly launches Alzheimer's drug donanemab in India at ₹91,688 ($957) per vial — LLY stock in focus
•LinkedIn plans 5% layoffs despite 12% revenue growth — MSFT stock affected
•Hot Sheet: Investment insights from ’s market experts for May 13